COVID-19 and Parkinson’s Disease
COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?
As one of the company’s priority diseases, CENTOGENE is continuously carrying out research into the causes of Parkinson’s disease (PD). A recurrent observation has been a temporal link of the development of PD to SARS-CoV-2 infections. Corroborating similar findings by others, a corresponding study was recently published in the Journal of Neurology.